These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 16337931

  • 1. The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients.
    Nikolova MH, Muhtarova MN, Taskov HB, Kostov K, Vezenkov L, Mihova A, Boumsell L, Bensussan A.
    Cell Immunol; 2005 Oct; 237(2):96-105. PubMed ID: 16337931
    [Abstract] [Full Text] [Related]

  • 2. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.
    J Infect Dis; 2001 Aug 01; 184(3):256-67. PubMed ID: 11443550
    [Abstract] [Full Text] [Related]

  • 4. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 01; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938
    [Abstract] [Full Text] [Related]

  • 6. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.
    Pontesilli O, Kerkhof-Garde S, Notermans DW, Foudraine NA, Roos MT, Klein MR, Danner SA, Lange JM, Miedema F.
    J Infect Dis; 1999 Jul 05; 180(1):76-86. PubMed ID: 10353864
    [Abstract] [Full Text] [Related]

  • 7. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H, Tsalimalma K, Dafni U, Dimitracopoulou A, Kordossis T.
    J Med Virol; 2004 Jun 05; 73(2):235-43. PubMed ID: 15122798
    [Abstract] [Full Text] [Related]

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 9. Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
    Gori A, Trabattoni D, Bandera A, Saresella M, Marchetti G, Gazzola L, Biasin M, Rhodes J, McDade H, Panebianco R, Galli M, Moroni M, Ferrante P, Thomas N, Franzetti F, Bray D, Clerici M.
    Antivir Ther; 2004 Aug 15; 9(4):603-14. PubMed ID: 15456092
    [Abstract] [Full Text] [Related]

  • 10. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
    Merino J, Ramírez N, Moreno C, Toledo E, Fernández M, Sánchez-Ibarrola A.
    Clin Exp Immunol; 2007 Jul 15; 149(1):87-96. PubMed ID: 17425655
    [Abstract] [Full Text] [Related]

  • 11. Characterization of murine CD160+ CD8+ T lymphocytes.
    Tsujimura K, Obata Y, Matsudaira Y, Nishida K, Akatsuka Y, Ito Y, Demachi-Okamura A, Kuzushima K, Takahashi T.
    Immunol Lett; 2006 Jul 15; 106(1):48-56. PubMed ID: 16764942
    [Abstract] [Full Text] [Related]

  • 12. The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
    Buseyne F, Scott-Algara D, Bellal N, Burgard M, Rouzioux C, Blanche S, Riviere Y.
    J Infect Dis; 2005 Nov 15; 192(10):1781-6. PubMed ID: 16235177
    [Abstract] [Full Text] [Related]

  • 13. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D.
    Antivir Ther; 2006 Nov 15; 11(1):105-16. PubMed ID: 16518966
    [Abstract] [Full Text] [Related]

  • 14. Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAART.
    Zidovec Lepej S, Kosor E, Gagro A, Vince A, Remenar A, Poljak M.
    Coll Antropol; 2006 Dec 15; 30 Suppl 2():33-8. PubMed ID: 17508471
    [Abstract] [Full Text] [Related]

  • 15. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.
    Clin Immunol; 2006 Nov 15; 121(2):191-7. PubMed ID: 16987710
    [Abstract] [Full Text] [Related]

  • 16. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L, Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, Izopet J, Israël N.
    J Virol; 2006 Oct 15; 80(20):10229-36. PubMed ID: 17005700
    [Abstract] [Full Text] [Related]

  • 17. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
    Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G.
    J Infect Dis; 2000 Apr 15; 181(4):1264-72. PubMed ID: 10751137
    [Abstract] [Full Text] [Related]

  • 18. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, Geng WQ, Jin X, Wang YN.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1966-71. PubMed ID: 17199940
    [Abstract] [Full Text] [Related]

  • 19. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L, Navarro J, Carbone J, Rodríguez-Sáinz C, Gil J, López F, Fernández-Cruz E, STIR-2102 Team.
    Vaccine; 2008 May 23; 26(22):2738-45. PubMed ID: 18433946
    [Abstract] [Full Text] [Related]

  • 20. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    Buseyne F, Le Chenadec J, Corre B, Porrot F, Burgard M, Rouzioux C, Blanche S, Mayaux MJ, Rivière Y.
    J Infect Dis; 2002 Dec 01; 186(11):1589-96. PubMed ID: 12447734
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.